Key point: AMT appears to be a safe treatment option for KCNQ2/3 GOF-related neurodevelopmental disorders, even in young children.
doi.org/10.1111/epi....

#epilepsy #ilae #KCNQ2 #KCNQ3 #neurodevelopmentaldelay #precision medicine